Last reviewed · How we verify
NCT04093713: NTALJ
A Novel Technique to Anaesthetize the Lower Jaw
NA trial testing A novel technique to block the inferior alveolar nerve block using Mepivecaine with Levonordefrin in Inferior Alveolar Nerve Block in 65 participants. Status unknown.
16 September 2019
Quick facts
| Lead sponsor | Mosaad Khalifah |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 65 |
| Start date | 14 September 2019 |
| Primary completion | 16 September 2019 |
| Estimated completion | 16 September 2019 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- A novel technique to block the inferior alveolar nerve block using Mepivecaine with Levonordefrin
Conditions studied
- Inferior Alveolar Nerve Block — all drugs for Inferior Alveolar Nerve Block →
Sponsor
Mosaad Khalifah
Who can join
Adults 5 to 55, any sex, with Inferior Alveolar Nerve Block. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study introduces and evaluates a new technique for inferior alveolar nerve blocking.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04093713
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Inferior Alveolar Nerve Block
Currently open trials in the same condition.
- NCT06806202 — Warm Versus Conventional 2% Lignocaine for IANB Efficacy · Phase 2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04093713 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Mosaad Khalifah
- Last refreshed: 18 September 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04093713.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing